Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Definiens Extends Functionality of Leading Image and Data Analysis Solutions for Digital Pathology

Published: Monday, May 13, 2013
Last Updated: Monday, May 13, 2013
Bookmark and Share
New product portfolio release significantly reduces hands-on time for tissue-based research.

Definiens announced at the 4th International Definiens Symposium on Harvard Medical School campus the launch of new software that improves productivity in tissue-based research and biomarker development. The new software extends the functionality of Definiens’ existing product portfolio and provides a significant quality control advantage, with up to a two-fold reduction in hands on time for researchers.

Inspired by customer feedback, the software removes a number of bottlenecks in the research process and features end-to-end workflow support from initial image analysis to final results. The efficient whole-slide review along with the smooth integration of image analysis and data mining capabilities significantly reduces hands-on time, increases productivity and accelerates the development of tissue-based biomarkers.

“The latest release of Definiens’ product suite represents the first end-to-end software solution for tissue-based research,” said Kai Hartmann, Director Product Marketing Life Sciences of Definiens. “Definiens customers can now experience the entire workflow process from digital image and metadata to the final result. We are dedicated to continually learn from our users and the discussions at the Symposium are a prime opportunity to obtain inspiration for ongoing product development.”

This latest version of Definiens’ product portfolio is being released at the 4th International Definiens Symposium taking place at the Joseph B. Martin Conference Center on Harvard Medical School campus in Boston, May 13-15, 2013. The Symposium is an annual event featuring more than 20 expert presenters, and represents a unique forum for thought leaders in digital pathology and tissue-based biomarker development to discuss the latest trends in quantitative research and cutting-edge biomedical image and data analysis. The event brings together experts from around the world to share best practices and learn from their approaches and experiences.

“As the leader in image and data analysis solutions for digital pathology, we are proud to be part of the impressive advances in disease diagnosis and patient outcomes being discussed at the 4th International Definiens Symposium,” said Thomas Heydler, CEO of Definiens. “The presentations and discussions highlight that image and data analysis expertise has become the definitive advantage in biomarker development and cancer biology.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,100+ scientific posters on ePosters
  • More Than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Definiens Secures € 15 Million for Tissue Phenomics-based Cancer Diagnostics
Big data approach bridges the gap between genomics and personalized medicine.
Saturday, June 28, 2014
Definiens Expands Management Team to Develop the Clinical Market
Company announces appointment of Pablo Jordan and Rebecca Berghorn.
Tuesday, October 29, 2013
Definiens Appoints Chief Marketing Officer, Merrilyn Datta, Ph.D.
Dr. Datta brings a wealth of experience in marketing and her expertise will be critical as Definiens expands its leadership in the life sciences and tissue diagnostics industries.
Tuesday, April 09, 2013
Definiens Establishes Advisory Board
Renowned industry experts to advise Definiens on clinical digital pathology market.
Thursday, March 28, 2013
Definiens Appoints Dr. Gerald Möller as Chairman of its Supervisory Board
Definiens AG announced that Dr. Gerald Möller, has joined the company's supervisory board as an independent member and has been appointed chairman.
Thursday, November 15, 2012
Definiens Closes €10 Million Round to Grow its Clinical Digital Pathology Business
The financing was led by new investor Gilde Healthcare Partners, a transatlantic investment firm with €450 million under management, focusing on the private healthcare sector.
Tuesday, October 02, 2012
Definiens Strengthens Leadership with Key Appointment
Former Aperio executive and digital pathology market expert, Dr. Martin Stuart, joins executive team.
Thursday, February 02, 2012
Definiens Digital Pathology Software Utilized for Hamner Institutes Liver Toxicology Study
Definiens TissueStudio™ and Definiens developer XD help quantify changes in apoptosis in the liver following chemical exposure.
Monday, June 07, 2010
Definiens Image Analysis Technology Improves Accuracy in Scoring Her2/neu in Breast Cancer Biopsies
New multi-dimensional image analysis platform aids diagnosis and treatment of breast cancer.
Wednesday, June 03, 2009
Definiens and Bioscan Team Up for Cooperative Marketing Efforts
Under the terms of the agreement, the companies will offer integrated solutions for intelligent small animal imaging analysis.
Wednesday, December 03, 2008
Scientific News
The Rise of 3D Cell Culture and in vitro Model Systems for Drug Discovery and Toxicology
An overview of the current technology and the challenges and benefits over 2D cell culture models plus some of the latest advances relating to human health research.
New NIH-EPA Research Centers to Study Environmental Health Disparities
Scientists will partner with community organizations to study these concerns and develop culturally appropriate ways to reduce exposure to harmful environmental conditions.
Structure of Essential Digestive Enzyme Uncovered
Using a powerful combination of techniques from biophysics to mathematics, researchers have revealed new insights into the mechanism of a liver enzyme that is critical for human health.
Air Pollution Linked to Heart Disease
10-year project revealed air pollutants accelerate plaque build-up in arteries to the heart.
Getting a Better Look at How HIV Infects and Takes Over its Host Cells
A new approach, developed by a team of researchers led by The Rockefeller University and The Aaron Diamond AIDS Research Center (ADARC), offers an unprecedented view of how a virus infects and appropriates a host cell, step by step.
Following Tricky Triclosan
Antibacterial product flows through streams, crops.
Vitamin A May Help Improve Pancreatic Cancer Chemotherapy
The addition of high doses of a form of vitamin A could help make chemotherapy more successful in treating pancreatic cancer, according to an early study by Queen Mary University of London (QMUL).
Poverty Marks a Gene, Predicting Depression
New study of high-risk teens reveals a biological pathway for depression.
World’s Largest Coral Gene Database
‘Genetic toolkit’ will help shed light on which species survive climate change.
A Boost for Regenerative Medicine
Growing tissues and organs in the lab for transplantation into patients could become easier after scientists discovered an effective way to produce three-dimensional networks of blood vessels, vital for tissue survival yet a current stumbling block in regenerative medicine.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!